scholarly journals Population and Health Policy Considerations

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 855-855
Author(s):  
Julie Robison

Abstract The risk of death, disease, disability, hospitalization, institutionalization and high health care costs varies among individuals with increasing heterogeneity associated with aging. Frailty, physical performance measures, self-reported measures and multimorbidity all represent measures that are useful in helping to better define such heterogeneity at the level of populations and to ultimately define such risk in individuals. These higher risk individuals account for a growing proportion of this nation’s health care costs, with continued increases over time that appear unsustainable in the long term. Therefore, efforts to better define the nature of such heterogeneity of risk and improved targeting, with the goals of improving outcomes and reducing costs, are essential. A closely related challenge is to effectively translate proven clinical and health system interventions from the world of research to that of health policy and real-world clinical practice via pragmatic trials.

PEDIATRICS ◽  
1989 ◽  
Vol 84 (1) ◽  
pp. A24-A24
Author(s):  
Student

Doctors, lawyers, architects, and other professionals strike a bargain with society: Leave us alone, they say, and we will take care of you. . . . But do professionals warrant the trust placed in their hands? Headlines shout of bridges and buildings toppling. Health care costs escalate. Our children compare poorly in knowledge of science, math, and foreign languages with those of other countries. Malpractice suits skyrocket. Greed corrupts Wall Street. America has lost the industrial muscle that was once the envy of the world. Has our army of experts, whom we entrust to take care of us, let us down? Or, on the other hand, have we let them down, shackling them in regulations, keeping them from doing their jobs, impeding them in the free exercise of their expertise?


2016 ◽  
Vol Volume 8 ◽  
pp. 407-412 ◽  
Author(s):  
Alessandro Roggeri ◽  
Daniela Paola Roggeri ◽  
Elisa Rossi ◽  
Salvatore Cataudella ◽  
Nello Martini

2020 ◽  
Vol 28 (6) ◽  
pp. 819-823
Author(s):  
L. Trenaman ◽  
D. Stacey ◽  
S. Bryan ◽  
K. Payne ◽  
G. Hawker ◽  
...  

2016 ◽  
Vol 263 (6) ◽  
pp. 1120-1128 ◽  
Author(s):  
Nete Munk Nielsen ◽  
Lise Kay ◽  
Benedikte Wanscher ◽  
Rikke Ibsen ◽  
Jakob Kjellberg ◽  
...  

2021 ◽  
Author(s):  
Bikash Bikram Thapa

Coronavirus disease 2019 (COVID-19) has put an unprecedented burden to world health, economy and social life with possible long-term consequences. The velocity and mass of this infection pandemic had already overwhelmed every robust health care system in the world. The evidence pertaining to this novel infection pandemic is evolving, so are the challenges in terms of adequate preparedness and response. In this review, we enumerate the strategic and operational domains and build a functional framework for the management of hospital mass infection incidents due to COVID-19 and similar future pandemics. This functional framework could assist health policy maker and health care worker to implement, innovate, and translate preparedness and response to save valuable life and resources.


2020 ◽  
Author(s):  
Mohsen Bayati ◽  
Khosro Keshavarz ◽  
Farhad Lotfi ◽  
Abbas KebriaeeZadeh ◽  
Omid Barati ◽  
...  

Abstract Background: Family physician program (FPP) and health transformation plan (HTP) are two major reforms that have been implemented in Iran's health system in recent. The present study was aimed at evaluating the impact of these two reforms on the level of service utilization and cost of health care services. Methods: This longitudinal study was conducted on people insured by social security organization in Fars province during 2009-2016. The data on the utilization of services and costs of general practitioner visits, specialist visits, medications, imaging, laboratory tests, and hospitalization were collected. Interrupted time series analysis was used to analyze the effect of the two mentioned reforms. Results: FPP resulted in a significant reduction in the number of specialist visits, imaging, and laboratory tests in the short term, and in the number of radiology services, laboratory tests, and hospitalization in the long term. In contrast, HTP significantly increased the utilization of radiology services and laboratory tests both in the short term and long term. Concerning the costs, FPP resulted in a reduction in costs in short and long term except general practitioners' and specialist visit, and medication in long term. However, HTP resulted in an increase in health care costs in both of the studied time periods. Conclusions: FPP has been successful in rationalizing the utilization of services. On the other hand, HTP has improved people’s access to services by increasing the utilization; but it has increased health care costs. Therefore, policymakers must adopt an agenda to revise and re-design the plan.


2017 ◽  
Vol 35 (8_suppl) ◽  
pp. 12-12 ◽  
Author(s):  
Eric Maiese ◽  
Kristin Evans ◽  
Bong-Chul Chu ◽  
Debra E. Irwin

12 Background: Survival among patients with multiple myeloma (MM)has improved over time, but little is known about concurrent changes in health care costs. This study examined trends in both survival and health care costs over the same time periods in U.S. patients with MM. Methods: The MarketScan Commercial and Medicare claims dataset was used to identify 5199 adult patients diagnosed with MM from Jan. 2006 to Dec. 2014. Patients had no prior evidence of cancer, were continuously enrolled for ≥ 12 months prior to MM diagnosis, and were followed through the earliest event (death, end of enrollment, or end of the study period (9/30/2015)). Multivariate GLM and Cox proportional hazards models estimated health care costs and survival probabilities, respectively, for two time periods during which patients were diagnosed with MM (2006-2010 vs. 2011-2014) while controlling for demographic and clinical characteristics. The recycled prediction method was used to calculate the incremental cost estimates between the time periods. Results: Patients diagnosed in 2011-2014 had a 35% lower risk of death compared to those diagnosed in 2006-2010 (HR [95% CI] = 0.65 [0.57-0.74]). Patients diagnosed in 2011-2014 had 18% (95% CI: 6-31%) higher all cause and 26% (95% CI: 6-50%) higher MM-related per patient per month costs compared to those diagnosed in 2006-2010 (see table). Conclusions: Among patients with MM, survival has improved at a greater rate than the increase in health care costs. In addition to improvements in MM treatment, changes in overall disease management may have contributed to both the increased expenditures and survival improvements observed in this study.[Table: see text]


2017 ◽  
Vol 52 (6) ◽  
pp. 2061-2078 ◽  
Author(s):  
Alison A. Galbraith ◽  
David J. Meyers ◽  
Dennis Ross-Degnan ◽  
Marguerite E. Burns ◽  
Catherine E. Vialle-Valentin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document